Melanoma (Skin) Stage IV Completed Phase 1 Trials for Nivolumab (DB09035)
Also known as: Stage 4 Melanoma / Melanoma Stage Iv / Stage IV Skin Melanoma / Stage IV Melanoma
Indication | Status | Phase |
---|---|---|
DBCOND0109891 (Melanoma (Skin) Stage IV) | Completed | 1 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02716948 | SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine | Treatment |